08:00-08:45 MEET WITH EXPERT MORNING SESSION 1 HALL 2 Treatment of challenging cases with type 2 diabetes: Diabetic patient with high CV risk, morbid obese patient with type 2 diabetes Discussion: Mustafa Kemal Balcı, İlhan Yetkin Case Presentation: Serdar Şahin 08:00-08:45 MEET WITH EXPERT MORNING SESSION 2 HALL 4 Follow-up and treatment of patients with challenging type 1 diabetes: Pregnant patient with type 1 diabetes, brittle type 1 diabetic patient Discussion: Taner Damcı, Metin Arslan Case Presentation: Özlem Haliloğlu 08:00-08:45 MEET WITH EXPERT MORNING SESSION 3 HALL 5 Management of diabetes in special situations: Diabetic patient with acute cardiovascular event, diabetic patient on enteral nutrition Discussion: Ahmet Çorakçı, Şazi İmamoğlu Case Presentation: Özge Korkmaz 09:00-09:45 CELAL ÖKER CONFERENCE HALL 1 Chairs: M. Temel Yılmaz, Hasan İlkova Islet transplantation for type 1 diabetes Betül Hatipoğlu 09:45-11:15 PANEL 2 HALL 1 Oral agents: Antidiabetic efficacy and safety Chairs: Nazif Bağrıaçık, Mustafa Kemal Balcı 09:45-10:00 Metformin Rıfat Emral 10:00-10:15 Sulphonylurea Füsun Baloş Törüner 10:15-10:30 Pioglitazone İbrahim Şahin 10:30-10:45 SGLT2i İlhan Tarkun 10:45-11:00 DPP4i Alev Altınova 11:00-11:15 Discussion 30
09:45-11:15 PANEL 3 HALL 2 Evidence based nutrition Chairs: Yüksel Altuntaş, Emel Özer 09:45-10:05 Effects of nutrient intake on microbiota Erol Bolu 10:05-10:25 Evidence for special diets: Low carbohydrate, low Emel Özer fat, ketogenic and others 10:25-10:45 Role of nutrition in prevention of diabetes: Mehmet Sargın Novel epidemiological data 10:45-11:05 Management of eating disorders associated Başak Yücel with diabetes 11:05-11:15 Discussion 11:15-11:45 Coffee break 11:45-12:45 SATELLITE SYMPOSIUM 1 HALL 1 Chair: Selçuk Dağdelen New horizons in weight management Hasan Aydın Kerem Dündar 11:45-12:45 SATELLITE SYMPOSIUM 2 HALL 2 Chair: Fırat Bayraktar Heart of diabetes Halil Önder Ersöz Ahmet Temizhan 12:45-13:30 A. SEVİM BÜYÜKDEVRİM CONFERENCE HALL 1 Chairs: Zeynep Oşar Siva, Füsun Saygılı Nonalcoholic fatty liver disease in type 2 diabetes: Risk, complications and management Kenneth Cusi 13:30-14:30 Lunch break 32
13:30-14:05 E-POSTER PRESENTATIONS 1 POSTER AREA SCREEN 1 Chair: Hasan Ali Altunbaş (PS-01 / PS-08) SCREEN 2 Chair: Meral Mert (PS-09 / PS-14) SCREEN 3 Chair: Ersin Akarsu (PS-15 / PS-21) 14:30-15:30 SATELLITE SYMPOSIUM 3 HALL 1 Chair: Kubilay Karşıdağ Expectations and realities in diabetes treatment Kürşad Ünlühızarcı Rüştü Serter Nesrin Dilbaz 14:30-15:30 SATELLITE SYMPOSIUM 4 HALL 2 Chair: Zeynep Oşar Siva Undisputable facts in changing treatment protocols Oğuzhan Deyneli Selçuk Dağdelen 15:30-16:15 ÜSTÜN KORUGAN CONFERENCE HALL 1 Chairs: Nevin Dinççağ, Sevim Güllü Psychology and treatment effectiveness of diabetic patient: What can be done? Khalida Ismail 16:15-16:30 Coffee break 16:30-17:30 PANEL 4 HALL 1 Pathophysiology panel Chairs: Ahmet Çorakçı, Nilgün Başkal 16:30-16:55 A different aspect on pathophysiology of Ahmet Kaya type 2 diabetes 16:55-17:20 What has changed in the pathophysiology of Nevin Dinççağ microvascular complications? 17:20-17:30 Discussion 34
16:30-17:30 PANEL 5 HALL 2 Diabetes and technology Chairs: İlhan Satman, Miyase Bayraktar 16:30-16:45 Latest advances in insulin pumps: Oğuzhan Deyneli Closed loop system and hybrid pump 16:45-17:00 Continuous glucose monitoring; advantages and Serpil Salman challenges 17:00-17:15 Telemedicine, social media and diabetes control Hasan Sav 17:15-17:30 Discussion 17:30-19:00 WORLDWIDE INITIATIVE FOR DIABETES EDUCATION HALL 1 Improving outcomes in the management of type 2 diabetes patients Chair: Abdullah Bennakhi 17:30-17:40 Welcome, introductions and objectives Abdullah Bennakhi 17:40-18:00 Hypoglycaemia in type 2 diabetes and its Kenneth Cusi impact on patient function and outcomes 18:00-18:20 When and how to intensify Abdullah Bennakhi insulin therapy? 18:20-18:40 Overview of CVOT trials with new treatments Hasan İlkova for diabetes 18:40-19:00 Panel discussion All faculty Question & answer session 36
7 TH MEETING OF DIABETES IN ASIA STUDY GROUP 25-27, APRIL 2019 18:10-19:20 ORAL PRESENTATIONS JOINT SESSION 1 HALL 2 (SS-01 / SS-07) SS-01 Chair: Nevin Dinççağ, Hussain Akhtar Evaluation of quality of life, beck anxiety and pittsburgh sleep quality in patients using sodium glucose cotransporter -2 inhibitor Serdar Şahin, Özge Polat Korkmaz, Özlem Haliloğlu, Emre Durcan, Hümeyra Rekalı Şahin, Volkan Demirhan Yumuk, Taner Damcı, Hasan İlkova, Zeynep Oşar Siva SS-02 SS-03 SS-04 SS-05 SS-06 SS-07 Retrospective evaluation of insulin degludec / insulin aspart (IDegAsp) co-formulation therapy in type 2 diabetes: A single center experience Özlem Haliloğlu, Merve Korkmaz, Özge Polat Korkmaz, Serdar Şahin, Emre Durcan, Taner Damcı, Hasan İlkova, Zeynep Oşar Siva Single center Glargine U-300 experience: Real life study Özge Polat Korkmaz, Duygu Sevinç Özgür, Gular Karimova, Özlem Haliloğlu, Serdar Şahin 1, Emre Durcan, Taner Damcı, Volkan Yumuk, Hasan İlkova, Zeynep Oşar Siva A rare cause of hypoglycemia: insulin autoimmune syndrome Emre Durcan, Rabia Hacer Hocaoğlu, Özge Polat Korkmaz, Serdar Şahin, Özlem Haliloğlu, Mutlu Güneş, Pınar Kadıoğlu Twelve-month changes in HbA1c, fasting plasma glucose, and weight among patients with type 2 diabetes in Turkey: Results from the global DISCOVER study Ramis Çolak, Mustafa Araz, Osman Başpınar, Onur Ütebay, Ferit Kerim Küçükler, Mehmet Çalan, Tamer Tetiker, Ceren Yılmaz, Yaşar Küçükardalı, Ramazan Sarı, Fahri Bayram Effect of ramadan fasting on glycemic control and cholesterol variables in diabetic patients Emel S. Gökmen, Kübra E. Yavuz Factors determining complete remission in type 1 diabetes Mehmet Temel Yılmaz, Begüm Demircan, Simge Su Şahin, Elif Şahiner, İremnur Yörük, Ecem Polat, Ramazan Çakmak 38
7 TH MEETING OF DIABETES IN ASIA STUDY GROUP 25-27, APRIL 2019 18:10-19:20 ORAL PRESENTATIONS JOINT SESSION 2 HALL 5 (SS-08 / SS-14) SS-08 SS-09 Chair: Metin Arslan, Viswanathan Mohan Turkish people s attitudes towards packaged foods Begüm Demircan, Murat Sarı, Mehmet Temel Yılmaz Factors affecting future glucose intolerance in women with a history of gestational diabetes (GDM)? Cemile İdiz, Fulya Çalıkoğlu, Ramazan Çakmak, Nurdan Gül, Mehmet Emin Unlu, Zeynep Nur Arı, Bita Motamedian, Hila Rafieipour, Elif Şahiner, Nevin Dinççağ SS-10 SS-11 SS-12 SS-13 SS-14 The utility of FIB-4 and NFS in assessing the advanced hepatic fibrosis in type 2 diabetic patients with biopsy proven nonalcoholic fatty liver disease Tasnim Alkayyalı, Lubna Quatranji, Eda Kaya, Alev Bakır, Yusuf Yılmaz Demographic and clinical characteristics of type 2 diabetic patients at the time of insulin initiation: a national, multicenter, retrospective study (INS-TUR Study) Abdurrahman Çömlekçi, Mine Adaş, Ayşegül Atmaca, Mustafa Araz, Ramazan Sarı, Ertuğrul Taşan, Tamer Tetiker, Abdurrahman Burak Ak The evaluation of the relationship of nonalcoholic fatty liver disease to duration of diabetes and chronic complications of diabetes in patients with type 2 diabetes mellitus Tuğba Kahraman Denizhan, Ahmet Kaya Effectiveness and safety of insulin glargine 300 U/ml in insulin-naïve patients with type 2 diabetes mellitus inadequately controlled on oral antidiabetic treatment in Turkey (EASE Study) Berrin Çetinarslan, Gülşah Nomak, Abrurrahman Burak Ak Seasonal variation in HbA1c and 25(OH) 2 Vitamin D concentrations in Turkish population Fulya Türker, Hülya Hacışahinoğulları, Ahmet Faruk Kılıçarslan, Reyhan Akas, Ayşe Kubat Üzüm, Beyhan Ömer, Sema Genç 40